[1]
A. A. Saiyed, M. Q. Darr, and S. S. Ghulam, “A review on the impact of the worldwide shortage of glucagon-like peptide-1 medications on control of diabetic patients”, Int J Community Med Public Health, vol. 11, no. 11, pp. 4523–4529, Oct. 2024.